Recognizing the financial burden of cancer patients in clinical trials

Oncologist

Volumn 20, Issue 6, 2015, Pages 572-575

  Nipp, Ryan D ^a   Powell, Elizabeth ^a   Chabner, Bruce ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

Clinical trial; Cost of illness; Financial support; Health care costs; Quality of life

Indexed keywords

ISOCITRATE DEHYDROGENASE;

BLOOD CELL COUNT; BONE MARROW BIOPSY; BREAST METASTASIS; CANCER PATIENT; CLINICAL RESEARCH; CLINICAL TRIAL; ECHOCARDIOGRAPHY; EDITORIAL; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH INSURANCE; HUMAN; LEUKEMIA; MALE; PATIENT PARTICIPATION; PRIORITY JOURNAL; SOCIAL STATUS; SOMATIC MUTATION; CLINICAL TRIAL (TOPIC); ECONOMICS; NEOPLASM;

CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS;

EID: 84932650981     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2015-0068     Document Type: Editorial

References (30)

1. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA 2004;291:2720–2726.
2. Scoggins JF, Ramsey SD. Anational cancer clinical trials system for the 21st century: Reinvigorating the NCI Cooperative Group Program. J Natl Cancer Inst 2010;102:1371.
3. Nass SJ, Moses HL, Mendelsohn J, eds. A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. Washington, DC: Institute of Medicine, 2010.
4. Fouad MN, Lee JY, Catalano PJ et al. Enrollment of patients with lung and colorectal cancers onto clinical trials. J Oncol Pract 2013;9:e40–e47.
5. Somkin CP, Altschuler A, Ackerson L et al. Organizational barriers to physician participation in cancer clinical trials. Am J Manag Care 2005;11: 413–421.
6. Fu S, McQuinn L, Naing A et al. Barriers to study enrollmentinpatientswithadvancedcancerreferred to a phase I clinical trials unit. The Oncologist 2013; 18:1315–1320.
7. Goldman DP, Schoenbaum ML, Potosky AL et al. Measuring the incremental cost of clinical cancer research. J Clin Oncol 2001;19:105–110.
8. Martin PJ, Davenport-Ennis N, Petrelli NJ et al. Responsibility for costs associated with clinical trials. J Clin Oncol 2014;32:3357–3359.
9. Lara PN Jr., Higdon R, Lim N et al. Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728–1733.
10. Goldman DP, Berry SH, McCabe MS et al. Incremental treatment costs in National Cancer Institute-sponsored clinical trials. JAMA 2003;289: 2970–2977.
11. Moy B, Polite BN, Halpern MT et al. American Society of Clinical Oncology policy statement: Opportunities in the Patient Protection and Affordable Care Act to reduce cancer care disparities. J Clin Oncol 2011;29:3816–3824.
12. Young RC. Cancer clinical trials—a chronic but curable crisis. N Engl J Med 2010;363:306–309.
13. Sateren WB, Trimble EL, Abrams J et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002;20: 2109–2117.
14. Baquet CR, Ellison GL, Mishra SI. Analysis of Maryland cancer patient participation in National Cancer Institute-supported cancer treatment clinical trials. J Clin Oncol 2008;26: 3380–3386.
15. Umutyan A, Chiechi C, Beckett LA et al. Overcoming barriers to cancer clinical trial accrual: Impact of a mass media campaign. Cancer 2008; 112:212–219.
16. Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004;22: 4626–4631.
17. Townsley CA, Selby R, Siu LL. Systematicreview of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 2005;23: 3112-3124.
18. Covinsky KE, Goldman L, Cook EF et al. The impact of serious illness on patients’ families. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. JAMA 1994;272:1839-1844.
19. Zafar SY, Peppercorn JM, Schrag D et al. The financial toxicity of cancer treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. The Oncologist 2013; 18:381-390.
20. Stump TK, Eghan N, Egleston BL et al. Cost concerns of patients with cancer. J Oncol Pract 2013; 9:251-257.
21. Bernard DS, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol 2011;29:2821-2826.
22. Emanuel EJ, Schnipper LE, Kamin DY et al. The costs of conducting clinical research. J Clin Oncol 2003;21:4145-4150.
23. Basch E, Snyder C, McNiff K et al. Patient-reported outcome performance measures in oncology. J Oncol Pract 2014;10:209-211.
24. Brundage M, Blazeby J, Revicki D et al. Patient-reported outcomes in randomized clinical trials: Development of ISOQOL reporting standards. Qual Life Res 2013;22:1161-1175.
25. Aaronson NK, Ahmedzai S, Bergman B et al.The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
26. Niezgoda HE, Pater JLA validation study of the domains of the core EORTC quality of life questionnaire. Qual Life Res 1993;2:319-325.
27. Nuzzo F, Morabito A, Gravina A et al. Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: Results of a single-centre randomized phase 3 trial. BMC Cancer 2011; 11:75.
28. Friends of the Clinical Center: Annual reports. Available at http://www.focccharities.org/Annual_ Reports.html. Accessed October 1, 2014.
29. Clinical development and trial operations (PH192): Protocol design and cost per patient benchmarks. Available at http://www.cuttingedgeinfo.com/research/clinical-development/trial-operations/ Accessed April 27,2015.
30. de Souza JA, Yap BJ, Hlubocky FJ et al. The development of a financial toxicity patient-reported outcome in cancer: The COSTmeasure. Cancer 2014; 120:3245-3253.